Angola vs Bosnia and Herzegovina: Deaths from Parkinson's disease
Angola
367.63 deaths
in 2021
Bosnia and Herzegovina
357.06 deaths
in 2021
Angola rank
75th
Bosnia and Herzegovina rank
77th
Deaths from Parkinson's disease over time
- Angola
- Bosnia and Herzegovina
How they compare
Angola currently reports 367.63 deaths against 357.06 deaths in Bosnia and Herzegovina, a difference of 10.57 deaths.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Angola ranks 75th and Bosnia and Herzegovina ranks 77th of 194 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Bosnia and Herzegovina in 2.
Head to head by decade
| Decade | Angola | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 170.01 deaths | 246.87 deaths | 76.86 deaths | Bosnia and Herzegovina |
| 2010s | 263.14 deaths | 312.27 deaths | 49.13 deaths | Bosnia and Herzegovina |
| 2020s | 367.89 deaths | 362.76 deaths | 5.13 deaths | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Angola or Bosnia and Herzegovina?
- Angola, at 367.63 deaths against 357.06 deaths in Bosnia and Herzegovina as of 2021.
- What is the difference in deaths from parkinson's disease between Angola and Bosnia and Herzegovina?
- 10.57 deaths, with Angola ahead.
- How many years of comparable data are there for Angola and Bosnia and Herzegovina?
- 22 years are reported by both, from 2000 to 2021.
- How do Angola and Bosnia and Herzegovina rank globally for deaths from parkinson's disease?
- Angola ranks 75th and Bosnia and Herzegovina ranks 77th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.